Various injectables and ophthalmics
Commercial- Indications
- Pain, Calcium deficiency, Nausea, Malaria, Anesthesia, Infection, Cardiovascular disease, Allergy, Iron deficiency, Glaucoma
Company intelligence / Profile preview
Somerset Therapeutics
Somerset, New Jersey, United Statessomersettherapeutics.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Somerset Therapeutics has six products currently on the market in the US. The company maintains a strong pipeline with approximately 25 additional products awaiting FDA approval. Its focus includes sterile injectable and ophthalmic generics for hospital and specialty use. The company’s manufacturing facilities are cGMP-compliant and have received regulatory approvals from agencies including the US FDA.
- Therapeutic areas
- OtherCardiovascularOphthalmologyInfectious Diseases
- Modalities
- Injectable drugsOphthalmic drugsOral solidsSmall molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Beyond the preview
Go deeper on Somerset Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Somerset Therapeutics.